Literature DB >> 29482961

Personalized prediction of drug efficacy for diabetes treatment via patient-level sequential modeling with neural networks.

Seokho Kang1.   

Abstract

Patients with type 2 diabetes mellitus are generally under continuous long-term medical treatment based on anti-diabetic drugs to achieve the desired glucose level. Thus, each patient is associated with a sequence of multiple records for prescriptions and their efficacies. Sequential dependencies are embedded in these records as personal factors so that previous records affect the efficacy of the current prescription for each patient. In this study, we present a patient-level sequential modeling approach utilizing the sequential dependencies to render a personalized prediction of the prescription efficacy. The prediction models are implemented using recurrent neural networks that use the sequence of all the previous records as inputs to predict the prescription efficacy at the time the current prescription is provided for each patient. Through this approach, each patient's historical records are effectively incorporated into the prediction. The experimental results of both the regression and classification analyses on real-world data demonstrate improved prediction accuracy, particularly for those patients having multiple previous records.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug failure prediction; Neural network; Personalized prediction; Sequential modeling; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 29482961     DOI: 10.1016/j.artmed.2018.02.004

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  3 in total

Review 1.  Artificial Intelligence Applications in Type 2 Diabetes Mellitus Care: Focus on Machine Learning Methods.

Authors:  Shahabeddin Abhari; Sharareh R Niakan Kalhori; Mehdi Ebrahimi; Hajar Hasannejadasl; Ali Garavand
Journal:  Healthc Inform Res       Date:  2019-10-31

2.  Application of three statistical models for predicting the risk of diabetes.

Authors:  Siyu Liu; Yue Gao; Yuhang Shen; Min Zhang; Jingjing Li; Pinghui Sun
Journal:  BMC Endocr Disord       Date:  2019-11-26       Impact factor: 2.763

3.  Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care.

Authors:  Yanguang Yang; Xiangqian Wang; Xiaopeng Yuan; Qiwei Zhu; Shusen Chen; Donglin Xia
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.